Legal Opinion
Rutledge v. Eli Lilly & Co.
Court of Appeals for the Seventh Circuit
Decided November 5, 2013No. 13-2113PublishedCited by 1 opinion
1Opinion of the Court
ORDER
In this diversity action, see 28 U.S.C. § 1332(a), Linda Rutledge appeals the dismissal of her complaint alleging that as a result of taking Zyprexa — an anti-psychotic drug manufactured by Eli Lilly and Company — she suffers from a variety of ailments including kidney problems, elevated blood pressure, and high cholesterol. We affirm.
Rutledge took Zyprexa in 1999, but did not sue Eli Lilly for her injuries for eleven years. When she sued in the district court for the Eastern District of New York, the court determined that, as a result of her delay, Rutledge’s claim was barred by the…
2Cases cited8 opinions
- Semtek International Inc. v. Lockheed Martin Corp.Supreme Court of the United States · 2001
- Bobby J. Anderson v. Alfred HardmanCourt of Appeals for the Seventh Circuit · 2001
- Smith v. Russell Sage CollegeNew York Court of Appeals · 1981
- Landau, P.C. v. LaRossa, Mitchell & RossNew York Court of Appeals · 2008
- United States v. Michael L. MorrisCourt of Appeals for the Seventh Circuit · 2001
3 more not listed; retrieve them via the Exa API.
3Cited by1 opinion
- Roumann Consulting Inc v. Symbiont Construction IncDistrict Court, E.D. Wisconsin · 2019